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The majority of pts with myeloma kidney didn’t have a previous MM diagnosis and the majority of pts submitted to renal biopsy didn’t have a MG previously identified. Although the reason for KB was different in the 3 major lesions identified, some pts with AL amyloidosis presented also myeloma kidney, as did half of the pts with LCDD.  Therefore, KB constitutes the gold standard to establish diagnosis and ascertain therapeutic in pts with MG and suspicion of renal involvement
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PATIENTS AND METHODSINTRODUCTION AND AIMS
Monoclonal gammopathies (MG) are a group of disorders
characterized by the proliferation of a clone of plasma cells,
This was a retrospective review of all kidney biopsies (KB)
performed in our laboratory in patients with MG in the last 30
RESULTS
70
80 73 69 Of these patients, only
frequently associated with organ dysfunction.
The most common MG are MG of undetermined significance
(MGUS), smoldering multiple myeloma, multiple myeloma (MM),
light-chain amyloidosis (AL) and monoclonal immunoglobulin
deposition disease (light chain and heavy chain deposition
disease).
The aim of this study was to evaluate the histological findings of
kidney biopsies and clinical data in patients with MG with or
years
Clinical data: age, gender, race, associated diseases, presence
of MM criteria, reason for biopsy, dialysis requirement
Laboratorial data: serum creatinine (Scr), 24h
proteinuria, presence of hematuria, serum and/or urinary
monoclonal protein, light chain classe
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179 9 49.2% were known to have a MG
9 24.5% were known to have MM
Myeloma kidney - 83
9 69 isolated myeloma kidney
9 2 with ATN,




kidney (n=69) LCDD (n=20)
Male gender (%) 42 5% (31) 42% (29) 55% (11)
Clinical characteristics
Morphologic characteristics
LCDD – Light chain deposition disease; HCDD – heavy chain deposition disease; 
TI nephrities – tubulointerstitial nephrities; IgA neph – IgA nephropathy; 
ATN – acute tubular necrosis; MP GN – membranoproliferative glomerulonephrities; 
FSGS – focal and segmental glomerulosclerosis; Malignant HT – malignant hypertension; 
DN – diabetic nephropathy  
9 1 with minimal change disease
9 1 with crescentic glomerulonephrities
9 10 associated with LCDD
9 4 associated with AL amyloidosis
.    
Age (years) 64.6±10 66±9.7 60.2±10.5
Caucasian race (%) 90.9% (40/44) 100% (30/30) 100% (11/11)
Dialysis requirement (%) 6.3% (4/63) 90% (36/40) 56.3% (9/16)
Presence of known MM (%) 12.3% (9) 39.1% (27) 25% (5)
Presence of known MG (%) 27.4% (20) 62.3% (43) 40% (8)
AL amyloidosis Myelomakidney LCDD
Mean glomeruli number 11.6±8.6 8.7±5.3 9.5±4.9
Mean lobulated glomeruli 0% 1.4% (1) 50% (10)
Mean sclerosed glomeruli 1.1±1 1±1.9 1±1.5
Myeloma kidney (%) 5.5% (4) 100% 50% (10)
Scr (mg/dl) 1.9±1.5 6.5±3.5 5.9±6
Proteinuria (g/24h) 7.3±5.8 2.4±4.4 5.2±3.2
Hematuria (%) 45.9% (17/37) 58.3% (14/24) 100% (5/5)



























No 30% (22) 4.3% (3) 5% (1)
Figure 2 – Cast nephropathy (Methenamine
Silver x 250) 
Figure 1 – Nodular glomerulosclerosis with
thickness of glomerular and tubular basement
membranes (Methenamine Silver x 400)
Non nephrotic proteinuria
Acute kidney injury














Light chain classe λ 82% (60) Λ 27; k 25 K 55% (11)
Heavy chain classe (n)














Other than k / λ 41.1% (30) 20.3% (14) 15% (3)
Figure 4 – AL amyloidosis (IF x 400)Figure 3 – Kappa light chain linear deposits
CONCLUSIONS
Contact of first author - karinadacostafer@hotmail.com
MG may be associated with a variety of renal disorders, some usually related to monoclonal chain, but others not typically related. 
The majority of patients with myeloma kidney didn’t have a previous MM diagnosis and the majority of patients submitted to renal biopsy didn’t have a MG previously identified. 
Although the reason for KB was different in the 3 major lesions identified, some patients with AL amyloidosis presented also myeloma kidney, as did half of the patients with LCDD.  
Therefore, KB constitutes the gold standard to establish diagnosis and ascertain therapeutic in patients with MG and suspicion of renal involvement.
IgG / IgA / IgM 16 / 7 / 1 / 0 11 / 6 / 0 / 1 1 / 0 / 2 / 0
       along the tubular basement membrane (IF x250)   
